title: Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease.
abstract: DNA polymorphisms at the endothelium constitutive nitric oxide synthase gene (NOS3) have been linked to the risk of developing coronary artery disease (CAD). In vitro, a polymorphism in the 5' region of the NOS3 gene (-786 T/C) influences promoter activity. This polymorphism has been associated with coronary spasms among Japanese. The genetic variation at the angiotensin-converting enzyme (ACE) is associated with plasma ACE activities and has also been linked with susceptibility to cardiovascular disease. Our objective was to determine if DNA polymorphisms in the NOS3 and ACE genes were associated with early CAD. We analyzed the -786 T/C polymorphism in the 5' flanking region and the 27-bp repeat polymorphism in NOS3 intron 4, as well as the ACE-I/D polymorphism. A total of 170 male smokers (CAD patients) younger than 50 years and 300 male smokers (healthy controls) were genotyped. Frequencies were compared by the chi(2) test, and odds ratios (ORs) and their 95% confidence intervals (CI) were also calculated. Only the -786 T/C polymorphism in the 5' flanking region of the NOS3 gene was significantly associated with early CAD in our population. The frequency of the CC genotype was significantly increased (P = 0.039) in patients compared to controls (OR = 1.67; 95% CI = 1.01, 2.72). We found a synergistic effect between the NOS3-CC and the ACE-DD genotypes in the risk of developing early CAD. The frequency of CC + DD was significantly increased among patients (P = 0.002). Thus, those with a NOS3-CC and an ACE-DD genotype would have a significantly increased risk of suffering an early episode of coronary artery disease (OR = 2.82; 95% CI = 1.40, 5.70). Although based on a limited number of patients, our work suggests that individuals who are NOS3-CC + ACE-DD are at a higher risk for early CAD, probably as a consequence of increased endothelial dysfunction.
authors.affiliation: Laboratorio de Genética Molecular-Instituto de Investigación Nefrológica, Hospital Central de Asturias, Oviedo, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Alvarez
authors.forename: P
authors.initials: P
authors.lastname: González
authors.forename: A
authors.initials: A
authors.lastname: Batalla
authors.forename: J R
authors.initials: JR
authors.lastname: Reguero
authors.forename: G
authors.initials: G
authors.lastname: Iglesias-Cubero
authors.forename: S
authors.initials: S
authors.lastname: Hevia
authors.forename: A
authors.initials: A
authors.lastname: Cortina
authors.forename: E
authors.initials: E
authors.lastname: Merino
authors.forename: I
authors.initials: I
authors.lastname: González
authors.forename: V
authors.initials: V
authors.lastname: Alvarez
authors.forename: E
authors.initials: E
authors.lastname: Coto
mesh_terms: D000328:Adult; D003327:Coronary Disease / Q000235:genetics* / Q000378:metabolism; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007438:Introns / Q000235:genetics; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000235:genetics* / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D007703:Peptidyl-Dipeptidase A / Q000235:genetics* / Q000378:metabolism; D011110:Polymorphism, Genetic / Q000235:genetics* / Q000502:physiology; D018570:Risk Assessment; D013030:Spain; D044465:White People / Q000235:genetics*
chemical_list: C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D007703:Peptidyl-Dipeptidase A